Insight Partners, a global software investor, and Northzone, an early-stage venture capital fund, led a $20m Series A round in Idoven, a pioneering health tech company advancing early detection and precision medicine of cardiovascular disease, with participation from Wayra. "The future of medicine requires deeply validated artificial intelligence deployed via API to augment clinicians, and this is especially true in cardiology given the importance of heart health and the explosion of monitoring technology. Idoven has the chance to improve healthcare and save lives, at scale. This is the essence of the type of software-driven technology and empathy that Insight looks for in early healthcare investments," Scott Barclay, Insight Partners Managing Director.